| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.92B | 42.80B | 42.08B | 41.10B | 51.02B | 32.85B |
| Gross Profit | 4.50B | 4.51B | 4.37B | 4.79B | 4.86B | 3.96B |
| EBITDA | 1.92B | 1.76B | 1.79B | 2.00B | 2.22B | 1.38B |
| Net Income | 453.00M | 342.00M | 382.00M | 626.00M | 694.00M | 367.00M |
Balance Sheet | ||||||
| Total Assets | 47.06B | 45.69B | 47.74B | 44.85B | 45.69B | 44.65B |
| Cash, Cash Equivalents and Short-Term Investments | 6.32B | 5.07B | 5.32B | 5.19B | 5.89B | 5.72B |
| Total Debt | 16.68B | 17.88B | 18.01B | 17.19B | 17.23B | 18.33B |
| Total Liabilities | 31.14B | 29.18B | 31.64B | 28.64B | 29.89B | 29.50B |
| Stockholders Equity | 15.49B | 16.07B | 15.66B | 15.78B | 15.32B | 14.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 264.00M | -97.00M | -185.00M | 1.68B | -1.87B |
| Operating Cash Flow | 0.00 | 1.11B | 906.00M | 503.00M | 2.33B | 398.00M |
| Investing Cash Flow | 0.00 | -650.00M | -1.03B | -741.00M | -613.00M | -1.60B |
| Financing Cash Flow | 0.00 | -590.00M | 235.00M | -472.00M | -1.56B | 622.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥66.66B | 9.74 | ― | 2.82% | 5.56% | 35.28% | |
78 Outperform | ¥50.24B | 11.52 | ― | 3.48% | 15.87% | 4.49% | |
74 Outperform | ¥362.82B | 6.04 | 11.34% | 3.38% | 4.23% | -14.22% | |
73 Outperform | ¥102.25B | 5.86 | ― | 3.74% | -3.93% | 3.02% | |
69 Neutral | ¥365.60B | 11.28 | ― | 3.13% | 1.59% | 18.87% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
49 Neutral | ¥6.23B | 26.16 | ― | 4.84% | 1.73% | -10.21% |